Prostate Cancer: Highlights from 2006

作者: Pierre Teillac , Pierre Mongiat-Artus

DOI: 10.1016/J.EURSUP.2007.03.016

关键词:

摘要: Abstract Objectives This review provides an overview of the most relevant findings on prostate cancer (PCa) presented at 2006 annual meetings European Association Urology, American Urological Association, and Society Clinical Oncology, which were discussed during "New Horizons in Urology" closed meeting Marbella, Spain, October 2006. Methods Experts field PCa selected new studies. In addition, participants' opinion two representative case studies was assessed by interactive voting, results commented experts. Results With regard to early detection PCa, it shown that there is no real PSA threshold. active surveillance indicated this a feasible strategy for carefully patients, but those patients with doubling time Conclusion Relevant data major urologic/oncologic have potential improve screening, detection, management disease.

参考文章(26)
Alan W. Partin, John Yoo, H. Ballentine Carter, Jay D. Pearson, Daniel W. Chan, Jonathan I. Epstein, Patrick C. Walsh, The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer The Journal of Urology. ,vol. 150, pp. 110- 114 ,(1993) , 10.1016/S0022-5347(17)35410-1
F. M. Calais Da Silva, F. Calais Da Silva, A. Bono, M. Brausi, P. Whelan, A. Queimadelos, J. Portillo, J. Portillo, Z. Kirkali, C. Robertson, Phase III intermittent MAB vs continuous MAB Journal of Clinical Oncology. ,vol. 24, pp. 4513- 4513 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.4513
L. Collette, U.E. Studer, P. Whelan, W. Albrecht, J. Casselman, T.M. De Reijke, D. Hauri, W. Loidl, S. Isorna, S.K. Sundaram, M. Debois, PSA DOUBLING TIME AS PREDICTOR OF OBJECTIVE PROGRESSION AND DEATH IN PATIENTS WITH T0-4 N0-2 M0 PROSTATE CANCER NOT SUITABLE FOR LOCAL DEFINITIVE TREATMENT ON WATCHFUL WAITING (EORTC 30891) European Urology Supplements. ,vol. 5, pp. 203- ,(2006) , 10.1016/S1569-9056(06)60727-6
Theresa J. Allain, Prostate cancer, osteoporosis and fracture risk. Gerontology. ,vol. 52, pp. 107- 110 ,(2006) , 10.1159/000090956
Jens Rassweiler, Michael Schulze, Dogu Teber, Othmar Seemann, Thomas Frede, Laparoscopic radical prostatectomy: functional and oncological outcomes. Current Opinion in Urology. ,vol. 14, pp. 75- 82 ,(2004) , 10.1097/00042307-200403000-00005
Theodorus H. van der Kwast, , Laurence Collette, Hein Van Poppel, Paul Van Cangh, Kris Vekemans, Luigi DaPozzo, Jean-François Bosset, Karl H. Kurth, Fritz H. Schröder, Michel Bolla, Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Archiv. ,vol. 449, pp. 428- 434 ,(2006) , 10.1007/S00428-006-0254-X
A. Heidenreich, C. Ohlmann, U. Engelmann, M. Schuhmacher, U. Studer, PARTIN TABLES DO NOT ADEQUATELY PREDICT THE RISK OF LYMPH NODE INVOLVEMENT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY Localised PROSTATE CANCER European Urology Supplements. ,vol. 5, pp. 280- ,(2006) , 10.1016/S1569-9056(06)61035-X
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74
M. Muntener, U. Kunz, K. Eichler, M. Puhan, D.M. Schmid, P. Jaeger, R.T. Strebel, DIAGNOSTIC YIELD OF A PSA THRESHOLD FOR PROSTATE BIOPSY OF 2.5 NG/ML COMPARED TO 4 NG/ML European Urology Supplements. ,vol. 5, pp. 237- ,(2006) , 10.1016/S1569-9056(06)60864-6